4D Molecular Therapeutics
Drug Discovery
4D Molecular Therapeutics valuation and funding history | Last updated: June 16, 2020 | 2 funding rounds
Current Valuation
N/A
As of June 16, 2020
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series C)
$75.0M
Last Funding
Jun 2020
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| June 16, 2020 | Later Stage VC (Series C) | $75.0M | N/A | - |
| September 5, 2018 | Early Stage VC (Series B) | $90.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
4D Molecular Therapeutics is currently valued at N/A as of June 16, 2020.
Explore More Data
Detailed analysis for 4D Molecular Therapeutics
What is 4D Molecular Therapeutics Worth in 2026?
4D Molecular Therapeutics is a leading private company in the Drug Discovery sector. Track 4D Molecular Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How 4D Molecular Therapeutics Valuation is Determined
Private company valuations like 4D Molecular Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.